STAT

Sam Isaly leaves OrbiMed months after harassment allegations

More than four months after promising to resign, Sam Isaly has stepped down from biotech’s most powerful hedge fund in the wake of allegations of rampant sexual harassment.

More than four months after from biotech’s most powerful hedge fund, Sam Isaly has stepped down from in the wake of allegations of rampant sexual harassment.

You're reading a preview, sign up to read more.

More from STAT

STAT2 min readScience
Pfizer Spends $11.4 Billion To Buy Array BioPharma For Its Cancer Drug Chemistry
Pfizer said it will spend $11.4 billion in cash to purchase Array BioPharma, a Boulder, Colo.-based biotech known as a top choice among biotechnology firms that need to synthesize new…
STAT4 min readSociety
Opinion: Ghost Networks Of Psychiatrists Make Money For Insurance Companies But Hinder Patients’ Access To Care
I tried calling a list of psychiatrists who supposedly took my insurance, but found a "ghost network" instead: Some were dead. Many weren't taking new patients. Others didn't take my…
STAT7 min readPolitics
Inhumane Or Unavoidable? As Congress Scrutinizes An Increase In Monkey Research, Scientists Defend Its Necessity
Scientists are relying on monkey research more than ever before. And now Congress wants the NIH and FDA to explain why.